BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston
Kyverna Therapeutics at BPI 2026
Sep 22–25, 2026 Boston, MA ~3k attendees Website
Kyverna Therapeutics takes part in 2 sessions at BPI 2026 in Boston. Its program centres on cell therapies for autoimmune disease and how to manufacture them at scale. One session describes development of next-generation cell therapies for autoimmune disease, and another draws lessons for faster, more affordable ex vivo cell therapy manufacturing.
| Organization | BPI 2026 Attendance |
|---|---|
Kyverna Therapeutics Emeryville, California | |
Clinical-stage biotechnology company developing CAR T-cell therapies for autoimmune diseases. | Panel Thu Sep 24 9:30am–10:30am Talk Fri Sep 25 11:15am–11:35am |
Find decision makers at Kyverna Therapeutics
Tell us what you sell and we’ll find the people at Kyverna Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction